AG NPP709 is currently on the market; however, no research has investigated the effect of AG NPP709 in patients with COPD. Thus, the goal of the study was To guage the efficacy of AG NPP709 in people with Continual bronchitis style COPD.Berberine suppresses inflammatory brokers-induced interleukin-1beta and tumor necrosis issue-alpha productions by